Elanco Animal Health Incorporated (ELAN) Institutional Ownership & Insider Trading

519 institutions reported holding Elanco Animal Health Incorporated shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ELANElanco Animal Health IncorporatedFollow ELAN — free

Drug Manufacturers - Specialty & Generic · Healthcare

—

Price chart with a free account

Market cap: 11.3B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 6 Nov, in 13 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

519 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	519	567	+3.9%	137	58	187	58
Mar 26	512	545	-3.0%	171	74	142	45
Dec 25	475	561	-2.3%	138	95	132	29
Sep 25	395	573	+6.4%	144	59	96	28
Jun 25	361	538	+8.3%	123	47	119	40
Mar 25	357	494	+1.5%	136	36	115	62
Dec 24	383	489	-1.2%	126	37	125	47
Sep 24	383	478	-1.1%	145	36	103	56

Elanco Animal Health Incorporated — questions

Who owns Elanco Animal Health Incorporated stock?: 519 institutions reported Elanco Animal Health Incorporated shares in 13F filings for the quarter ended 2026-06-30. The largest: Dodge & Cox (13.5%), FMR LLC (11.4%), BlackRock, Inc. (9.8%).
Are Elanco Animal Health Incorporated insiders buying or selling?: 13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Elanco Animal Health Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.